Please see below for a list of search results.
This document describes the HTA’s policy on the management and traceability of tissue samples retained by independent pathologists when undertaking post mortem examinations (PME) at HTA-licensed premises where they are not employed.
The aims of this policy are:
The HTA has updated its protocol to ensure the provision of forensic pathology services in the event of regulatory action taken in England and Wales.
This document aims to provide an overview of the Human Tissue Authority’s (HTA) role in the regulation of post-mortem examination. It also aims to provide leaders of services and board members with an overview of the key strategic issues facing mortuaries and of the potential consequences when...